Recombinant Human Complement receptor type 1(CR1),partial CSB-EP005932HU
Specifications
| 20ug / 100ug / 1mg price = 100ug |
Alternative Name(s):
C3b/C4b receptor CD_antigen: CD35
Species: (Organism)
Homo sapiens (Human)
Gene Names:
CR1
Tag info:
N-terminal GST-tagged
Target Protein AA Sequence:
GQCNAPEWLPFARPTNLTDEFEFPIGTYLNYECRPGYSGRPFSIICLKNSVWTGAKDRCRRKSCRNPPDPVNGMVHVIKGIQFGSQIKYSCTKGYRLIGSSSATCIISGDTVIWDNETPICDRIPCGLPPTITNGDFISTNRENFHYGSVVTYRCNPGSGGRKVFELVGEPSIYCTSNDDQVGIWSGPAPQCII
Expression Region:
41-234aa
Subcellular Location:
Membrane, Single-pass type I membrane protein
Tissue Specificity:
Present on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells.
Protein Length:
Partial
Pathway:
Complementandcoagulationcascades
Mol. Weight:
48.4 kDa
Purity:
Greater than 90% as determined by SDS-PAGE.
Form:
Liquid or Lyophilized powder
Buffer:
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Research Areas:
Others
Function:
Mediates cellular binding of particles and immune complexes that have activated complement.; FUNCTION
Involvement in disease:
Relevance:
Mediates cellular binding of particles and immune complexes that have activated complement. (Microbial infection) Acts as a receptor for Epstein-Barr virus.
Reconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Protein Families:
Receptors of complement activation (RCA) family
Reference:
"Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis."Klickstein L.B., Bartow T.J., Miletic V., Rabson L.D., Smith J.A., Fearon D.T.J. Exp. Med. 168:1699-1717(1988)
